Liu J, Li P, Zhang Y, Zheng L
Sci Rep. 2025; 15(1):8209.
PMID: 40065044
PMC: 11893791.
DOI: 10.1038/s41598-025-91299-z.
Ma L, Luan Y, Lu L
Cancer Med. 2025; 14(5):e70622.
PMID: 40062730
PMC: 11891933.
DOI: 10.1002/cam4.70622.
Khan Y, Rizvi S, Raza A, Khan A, Hussain S, Khan N
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40029385
DOI: 10.1007/s00210-025-03896-4.
Xiao L, Shen Z, Pan Z, Qiu Y, Huang D, Liu Y
J Transl Med. 2025; 23(1):254.
PMID: 40025504
PMC: 11872339.
DOI: 10.1186/s12967-025-06299-4.
Li J, Xu Y, Han Y, Yang A, Qian M, Wang B
Medicine (Baltimore). 2025; 104(5):e41393.
PMID: 39889187
PMC: 11789896.
DOI: 10.1097/MD.0000000000041393.
Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC.
Chen K, Li X, Dong S, Guo Y, Luo Z, Zhuang S
J Transl Med. 2025; 23(1):27.
PMID: 39780232
PMC: 11707955.
DOI: 10.1186/s12967-024-06036-3.
Elucidating the molecular and immune interplay between head and neck squamous cell carcinoma and diffuse large B-cell lymphoma through bioinformatics and machine learning.
Zheng J, Li X, Gong X, Hu Y, Tang M
Transl Cancer Res. 2024; 13(11):5725-5750.
PMID: 39697749
PMC: 11651739.
DOI: 10.21037/tcr-24-1064.
Single-nucleus CUT&RUN elucidates the function of intrinsic and genomics-driven epigenetic heterogeneity in head and neck cancer progression.
Womersley H, Muliaditan D, DasGupta R, Cheow L
Genome Res. 2024; 35(1):162-177.
PMID: 39622638
PMC: 11789629.
DOI: 10.1101/gr.279105.124.
Constructing methylation-driven ceRNA networks unveil tumor heterogeneity and predict patient prognosis.
Li X, Peng C, Liu H, Dong M, Li S, Liang W
Hum Mol Genet. 2024; 34(3):251-264.
PMID: 39603659
PMC: 11792255.
DOI: 10.1093/hmg/ddae176.
Spatial transcriptomics reveals molecular cues underlying the site specificity of the adult mouse oral mucosa and its stem cell niches.
Seubert A, Krafft M, Bopp S, Helal M, Bhandare P, Wolf E
Stem Cell Reports. 2024; 19(12):1706-1719.
PMID: 39547226
PMC: 11751799.
DOI: 10.1016/j.stemcr.2024.10.007.
Spatial and Single-Cell Transcriptomics Unraveled Spatial Evolution of Papillary Thyroid Cancer.
Zheng G, Chen S, Ma W, Wang Q, Sun L, Zhang C
Adv Sci (Weinh). 2024; 12(2):e2404491.
PMID: 39540244
PMC: 11727256.
DOI: 10.1002/advs.202404491.
Type I Interferon Drives a Cellular State Inert to TCR-Stimulation and Could Impede Effective T-Cell Differentiation in Cancer.
Corvino D, Batstone M, Hughes B, Kempchen T, Ng S, Salim N
Eur J Immunol. 2024; 55(1):e202451371.
PMID: 39529512
PMC: 11739669.
DOI: 10.1002/eji.202451371.
FBXO2 as a switch guides a special fate of tumor clones evolving into a highly malignant transcriptional subtype in oral squamous cell carcinoma.
Cheng J, Liu O, Bin X, Tang Z
Apoptosis. 2024; 30(1-2):167-184.
PMID: 39487312
DOI: 10.1007/s10495-024-02033-5.
Lipids in the tumor microenvironment: immune modulation and metastasis.
Pascual G, Benitah S
Front Oncol. 2024; 14:1435480.
PMID: 39391242
PMC: 11464260.
DOI: 10.3389/fonc.2024.1435480.
SOX4-BMI1 axis promotes non-small cell lung cancer progression and facilitates angiogenesis by suppressing ZNF24.
Wen T, Zhang X, Gao Y, Tian H, Fan L, Yang P
Cell Death Dis. 2024; 15(9):698.
PMID: 39349443
PMC: 11442842.
DOI: 10.1038/s41419-024-07075-w.
CD133/ABCC5 cervical cancer cells exhibit cancer stem cell properties.
He L, Qian H, Seyiti A, Yang C, Shi N, Chen C
Heliyon. 2024; 10(17):e37066.
PMID: 39296204
PMC: 11408061.
DOI: 10.1016/j.heliyon.2024.e37066.
Nuclear lamin A/C phosphorylation by loss of androgen receptor leads to cancer-associated fibroblast activation.
Ghosh S, Isma J, Ostano P, Mazzeo L, Toniolo A, Das M
Nat Commun. 2024; 15(1):7984.
PMID: 39266569
PMC: 11392952.
DOI: 10.1038/s41467-024-52344-z.
TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma.
Chen Z, Cai H, Ye W, Wu J, Liu J, Xie Y
Front Immunol. 2024; 15:1445472.
PMID: 39234254
PMC: 11371717.
DOI: 10.3389/fimmu.2024.1445472.
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression.
Tomecka P, Kunachowicz D, Gorczynska J, Gebuza M, Kuznicki J, Skinderowicz K
Int J Mol Sci. 2024; 25(16).
PMID: 39201656
PMC: 11354349.
DOI: 10.3390/ijms25168972.
Head and neck cancer: pathogenesis and targeted therapy.
Liu Y, Zhang N, Wen Y, Wen J
MedComm (2020). 2024; 5(9):e702.
PMID: 39170944
PMC: 11338281.
DOI: 10.1002/mco2.702.